<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00831688</url>
  </required_header>
  <id_info>
    <org_study_id>Meniere trial 037/05</org_study_id>
    <nct_id>NCT00831688</nct_id>
  </id_info>
  <brief_title>Efficacy of Local Overpressure Treatment for Meniere's Disease</brief_title>
  <official_title>Phase 3 Study of Efficacy of Local Overpressure Treatment for Meniere's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum der Universitaet Muenchen, Grosshadern</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinikum der Universitaet Muenchen, Grosshadern</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study to date, is that no causal therapy for Meniere's disease has been
      discovered. Local overpressure treatment for Meniere's disease is a new treatment form that
      has been shown in animal and human experiments to reduce the endolymphatic hydrops, a
      condition that is generally believed to be the pathologic hallmark of Meniere's disease. This
      study analyzes the efficacy of local overpressure treatment by measuring subjective vertigo
      severity and objective audiovestibular function parameters.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized double-blind controlled trial. Patients with unilateral Meniere's disease that
      suffer from recurring vertigo attacks are allocated to either a verum or a placebo device and
      are treated for 4 months. Before during and after the treatment period, subjective and
      objective audiovestibular function parameters are measured.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in vertigo score from pre-therapy to post-therapy. (Vertigo score = summation of daily vertigo severity over 4 weeks. Daily vertigo score = a number between = and 4.)</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pure tone audiometric thresholds</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech recognition hearing levels</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Horizontal semicircular canal paresis</measure>
    <time_frame>4 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Daily Activity levels (Number between 0 and 4)</measure>
    <time_frame>4 Months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Meniere's Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Local overpressure treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Meniett(C) device by MedTronic</intervention_name>
    <description>pulsed pressure application, up to 12 cm H20 column, 3 times daily for 5 minutes, generated by Meniett device and conducted to middle ear cavity via tympanostomy tube</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Meniett</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>placebo treatment</intervention_name>
    <description>device seemingly identical to active device, manufactured by Medtronic. 3 times daily for 5 minutes.Produces similar sound effect, but without pulsed pressure elevation.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  unilateral definite Meniere's disease according to the AAO-HNS criteria

        Exclusion Criteria:

          -  previous destructive treatment (gentamicin, saccotomy, vestibular neurectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eike Krause, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LMU Munich, Department of ENT</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Gürkov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LMU Munich, Department of ENT</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinik für Hals-Nasen-Ohrenheilkunde</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2009</study_first_submitted>
  <study_first_submitted_qc>January 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2009</study_first_posted>
  <last_update_submitted>April 20, 2009</last_update_submitted>
  <last_update_submitted_qc>April 20, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Eike Krause</name_title>
    <organization>Klinikum der Universitaet Muenchen, Grosshadern</organization>
  </responsible_party>
  <keyword>Meniere</keyword>
  <keyword>vertigo</keyword>
  <keyword>overpressure treatment</keyword>
  <keyword>caloric irrigation</keyword>
  <keyword>hearing levels</keyword>
  <keyword>vertigo severity</keyword>
  <keyword>functional disability scale</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meniere Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

